| 1 | Children with sickle cell disease and fever but no respiratory symptoms: Is a chest x-ray needed? (Khan NI, Coleman KD, Nimmer M, Brazauskas R, Brousseau DC) Am J Emerg Med 2025 Mar;89:75-77 |
| 1 | Beyond IV push: alternative methods for management of acute pain in SCD. (Azul M, Brandow AM) Hematology Am Soc Hematol Educ Program 2024 Dec 06;2024(1):611-617 |
| 1 | Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease. (Walters MC, Eapen M, Liu Y, El Rassi F, Waller EK, Levine JE, Strouse JJ, Antin JH, Parikh SH, Bakshi N, Dampier C, Jaroscak JJ, Bergmann S, Wong T, Kota V, Pace B, Lekakis LJ, Lulla P, Nickel RS, Kasow KA, Popat U, Smith W, Yu L, DiFronzo N, Geller N, Kamani N, Klings ES, Hassell K, Mendizabal A, Sullivan K, Neuberg D, Krishnamurti L) Blood Adv 2025 Mar 11;9(5):955-965 |
| 1 | Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease. (John TD, Walters MC, Rangarajan HG, Rahim MQ, McKinney C, Bollard CM, Abusin G, Eapen M, Kassim AA, DeBaun MR) Blood Adv 2024 Dec 10;8(23):6055-6063 |
| 1 | International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the current state of hematopoietic stem and progenitor cell-based genomic therapies and the challenges faced. (Gupta AO, Azul M, Bhoopalan SV, Abraham A, Bertaina A, Bidgoli A, Bonfim C, DeZern A, Li J, Louis CU, Purtill D, Ruggeri A, Boelens JJ, Prockop S, Sharma A) Cytotherapy 2024 Nov;26(11):1411-1420 2 Citations |
| 1 | Acute care utilization among individuals with sickle cell disease and related cardiopulmonary and renal complications. (Singh A, Brousseau DC, Dasgupta M, Shet AS, Field JJ, Brandow AM) PLoS One 2024;19(4):e0297469 1 Citation |
| 2 | Sickle cell disease iPSC-derived sensory neurons exhibit increased excitability and sensitization to patient plasma. (Allison RL, Welby E, Ehlers V, Burand A, Isaeva O, Nieves Torres D, Highland J, Brandow AM, Stucky CL, Ebert AD) Blood 2024 May 16;143(20):2037-2052 1 Citation |
| 5 | Sterile inflammation induces vasculopathy and chronic lung injury in murine sickle cell disease. (Rarick KR, Li K, Teng RJ, Jing X, Martin DP, Xu H, Jones DW, Hogg N, Hillery CA, Garcia G, Day BW, Naylor S, Pritchard KA Jr) Free Radic Biol Med 2024 Mar;215:112-126 3 Citations |
| 1 | Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial. (Rees CA, Brousseau DC, Cohen DM, Villella A, Dampier C, Brown K, Campbell A, Chumpitazi CE, Airewele G, Chang T, Denton C, Ellison A, Thompson A, Ahmad F, Bakshi N, Coleman KD, Leibovich S, Leake D, Hatabah D, Wilkinson H, Robinson M, Casper TC, Vichinsky E, Morris CR, SCD Arginine Study Group and PECARN) Trials 2023 Aug 17;24(1):538 6 Citations |
| 1 | Sickle Cell Virtual Support Group Program for Adults: An Implementation Evaluation. (Clayton-Jones D, Ong LZ, Bekhet AK, Jones W, Ontala E, Pena S, Griffin K, Griffin J, Peacock E, Haglund K) Issues Ment Health Nurs 2023 Aug;44(8):758-766 1 Citation |
| 2 | A mass spectrometry assay for detection of endogenous and lentiviral engineered hemoglobin in cultured cells and sickle cell disease mice. (Wang X, McKillop WM, Dlugi TA, Faber ML, Alvarez-Argote J, Chambers CB, Wilber A, Medin JA) J Gene Med 2024 Jan;26(1):e3567 |
| 1 | Return visit rates after an emergency department discharge for children with sickle cell pain episodes. (Coleman KD, McKinley K, Ellison AM, Alpern ER, Hariharan S, Topoz I, Wurtz M, Nielsen B, Cook LJ, Morris CR, Brandow AM, Campbell AD, Liem RI, Nuss R, Quinn CT, Thompson AA, Villella A, King AA, Baumann A, Frankenberger W, Brousseau DC) Pediatr Blood Cancer 2023 Oct;70(10):e30553 1 Citation |
| 2 | Return visits after emergency department treatment for sickle cell pain crises. (Walsh PS, Brousseau DC, Coleman KD) Am J Hematol 2023 Oct;98(10):E266-E268 1 Citation |
| 1 | Potent and uniform fetal hemoglobin induction via base editing. (Mayuranathan T, Newby GA, Feng R, Yao Y, Mayberry KD, Lazzarotto CR, Li Y, Levine RM, Nimmagadda N, Dempsey E, Kang G, Porter SN, Doerfler PA, Zhang J, Jang Y, Chen J, Bell HW, Crossley M, Bhoopalan SV, Sharma A, Tisdale JF, Pruett-Miller SM, Cheng Y, Tsai SQ, Liu DR, Weiss MJ, Yen JS) Nat Genet 2023 Jul;55(7):1210-1220 32 Citations |
| 1 | Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study. (Singh A, Sontag MK, Zhou M, Dasgupta M, Crume T, McLemore M, Galadanci N, Randall E, Steiner N, Brandow AM, Koch K, Field JJ, Hassell K, Snyder AB, Kanter J) JMIR Public Health Surveill 2023 Jun 28;9:e42816 2 Citations |
| 1 | Risk of Bacteremia in Febrile Children and Young Adults With Sickle Cell Disease in a Multicenter Emergency Department Cohort. (Rineer S, Walsh PS, Smart LR, Harun N, Schnadower D, Lipshaw MJ) JAMA Netw Open 2023 Jun 01;6(6):e2318904 3 Citations |
| 3 | Preliminary construct validity of patient-reported outcomes to assess chronic pain in adults with sickle cell disease. (Mucalo L, Field JJ, Highland J, Khan H, Hankins JS, Singh A, Brandow AM) Blood Adv 2023 Jul 25;7(14):3658-3665 4 Citations |
| 1 | Peripheral transient receptor potential vanilloid type 4 hypersensitivity contributes to chronic sickle cell disease pain. (Ehlers VL, Sadler KE, Stucky CL) Pain 2023 Aug 01;164(8):1874-1886 5 Citations |
| 2 | Comparison of CAT and short forms for PROMIS pain and physical health domains in children with sickle cell disease. (Mason SF, Dasgupta M, Flynn KE, Simpson PM, Singh A) J Patient Rep Outcomes 2023 Feb 14;7(1):12 |
| 1 | Refractory Pneumonia in a 12-year-old Girl with Hemoglobin SS Disease. (Tregoning VG, Parran K, Watson AS, Mitchell ML) Pediatr Rev 2023 Feb 01;44(2):100-103 |
| 2 | Surveillance for the Rare Condition of Sickle Cell Disease in Wisconsin. (Singh A, Dasgupta M, Retherford D, Baker M, Hulihan M, Brandow AM) WMJ 2022 Dec;121(4):297-300 2 Citations |
| 4 | Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease. (Eapen M, Brazauskas R, Williams DA, Walters MC, St Martin A, Jacobs BL, Antin JH, Bona K, Chaudhury S, Coleman-Cowger VH, DiFronzo NL, Esrick EB, Field JJ, Fitzhugh CD, Kanter J, Kapoor N, Kohn DB, Krishnamurti L, London WB, Pulsipher MA, Talib S, Thompson AA, Waller EK, Wun T, Horowitz MM) J Clin Oncol 2023 Apr 20;41(12):2227-2237 24 Citations |
| 2 | Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease. (Chu Y, Talano JA, Baxter-Lowe LA, Verbsky JW, Morris E, Mahanti H, Ayello J, Keever-Taylor C, Johnson B, Weinberg RS, Shi Q, Moore TB, Fabricatore S, Grossman B, van de Ven C, Shenoy S, Cairo MS) Front Immunol 2022;13:1055497 1 Citation |
| 2 | A perspective on the sickle cell disease international COVID-19 registry. (Mucalo L, Brandow AM, Singh A) Best Pract Res Clin Haematol 2022 Sep;35(3):101385 2 Citations |
| 1 | Chronic Pain: Prevalence and Management. (Carroll CP, Brandow AM) Hematol Oncol Clin North Am 2022 Dec;36(6):1151-1165 5 Citations |
| 1 | Characterising the prevalence of overweight and obese status among adults with sickle cell disease. (Ibemere SO, Oyedeji CI, Preiss L, Van Althuis LE, Hankins JS, Azul M, Burns EN, Glassberg J, Hagar W, Hussain F, King A, Melvin C, Myers J, Snyder A, Shah N, Tanabe P, Sickle Cell Disease Implementation Consortium) Br J Haematol 2023 Mar;200(5):633-642 3 Citations |
| 2 | Pathophysiological characterization of the Townes mouse model for sickle cell disease. (Alvarez-Argote J, Dlugi TA, Sundararajan T, Kleynerman A, Faber ML, McKillop WM, Medin JA) Transl Res 2023 Apr;254:77-91 6 Citations |
| 1 | Hypoxic storage of donor red cells preserves deformability after exposure to plasma from adults with sickle cell disease. (Karafin MS, Field JJ, Ilich A, Li L, Qaquish BF, Shevkoplyas SS, Yoshida T) Transfusion 2023 Jan;63(1):193-202 4 Citations |
| 1 | Enrollment Lessons from a Biological Assignment Study of Marrow Transplantation versus Standard Care for Adolescents and Young Adults with Sickle Cell Disease: Considerations for Future Gene and Cellular Therapy Trials. (Krishnamurti L, Neuberg D, Sullivan KM, Smith S, Eapen M, Walters MC) Transplant Cell Ther 2023 Apr;29(4):217-221 4 Citations |
| 1 | Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with sickle cell disease. (Hulbert ML, Fields ME, Guilliams KP, Bijlani P, Shenoy S, Fellah S, Towerman AS, Binkley MM, McKinstry RC, Shimony JS, Chen Y, Eldeniz C, Ragan DK, Vo K, An H, Lee JM, Ford AL) Blood 2023 Jan 26;141(4):335-344 16 Citations |
| 1 | Hypothesis: Low Vitamin A and D Levels Worsen Clinical Outcomes When Children with Sickle Cell Disease Encounter Parvovirus B19. (Penkert RR, Azul M, Sealy RE, Jones BG, Dowdy J, Hayden RT, Tang L, Ross AC, Hankins JS, Hurwitz JL) Nutrients 2022 Aug 19;14(16) 4 Citations |
| 1 | Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations. (Woodard KJ, Doerfler PA, Mayberry KD, Sharma A, Levine R, Yen J, Valentine V, Palmer LE, Valentine M, Weiss MJ) Dis Model Mech 2022 Jun 01;15(6) 8 Citations |
| 2 | COVID-19 and venous thromboembolism risk in patients with sickle cell disease. (Singh A, Brandow AM, Wun T, Shet AS) Blood Adv 2022 Aug 09;6(15):4408-4412 5 Citations |
| 1 | A Standardized Emergency Department Order Set Decreases Admission Rates and In-Patient Length of Stay for Adults Patients with Sickle Cell Disease. (Wachnik AA, Welch-Coltrane JL, Adams MCB, Blumstein HA, Pariyadath M, Robinson SG, Saha A, Summers EC, Hurley RW) Pain Med 2022 Dec 01;23(12):2050-2060 4 Citations |
| 1 | "Into the Lion's Den": COVID-19 Experiences of Black Adults with Sickle Cell Disease. (Matthie NS, Clayton-Jones DL, Jenerette CM) Qual Health Res 2022 Jul;32(8-9):1328-1341 7 Citations |
| 1 | Microfluidic methods to advance mechanistic understanding and translational research in sickle cell disease. (Azul M, Vital EF, Lam WA, Wood DK, Beckman JD) Transl Res 2022 Aug;246:1-14 2 Citations |
| 2 | Long-term Survival after Hematopoietic Cell Transplant for Sickle Cell Disease Compared to the United States Population. (St Martin A, Hebert KM, Serret-Larmande A, Jouhet V, Hughes E, Stedman J, DeSain T, Pillion D, Lyons JC, Steinert P, Avillach P, Eapen M) Transplant Cell Ther 2022 Jun;28(6):325.e1-325.e7 8 Citations |
| 1 | Advances in the diagnosis and treatment of sickle cell disease. (Brandow AM, Liem RI) J Hematol Oncol 2022 Mar 03;15(1):20 92 Citations |
| 1 | Significant improvement of child physical and emotional functioning after familial haploidentical stem cell transplant. (Parsons SK, Rodday AM, Weidner RA, Morris E, Braniecki S, Shenoy S, Talano JA, Moore TB, Panarella A, Flower A, Milner J, Fabricatore S, Mahanti H, van de Ven C, Shi Q, Cairo MS) Bone Marrow Transplant 2022 Apr;57(4):586-592 3 Citations |
| 1 | Non-crisis related pain occurs in adult patients with sickle cell disease despite chronic red blood cell exchange transfusion therapy. (Curtis SA, Raisa BM, Roberts JD, Hendrickson JE, Starrels J, Lesley D, Michelle D, Daniel Z, Brandow AM) Transfus Apher Sci 2022 Apr;61(2):103304 4 Citations |
| 1 | Ionophore-mediated swelling of erythrocytes as a therapeutic mechanism in sickle cell disease. (Geisness AC, Azul M, Williams D, Szafraniec H, De Souza DC, Higgins JM, Wood DK) Haematologica 2022 Jun 01;107(6):1438-1447 4 Citations |
| 1 | Treatment-related Correlates of Growth in Children With Sickle Cell Disease in the DISPLACE Cohort. (Galadanci NA, Sohail M, Akinyelure OP, Kanter J, Ojesina AI) J Pediatr Hematol Oncol 2022 Jul 01;44(5):249-254 4 Citations |
| 1 | Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry. (Wilson SR, Sears M, Williams E, Drapekin J, Sivakumar I, Padrino S, Desai PC, Hager W, Manwani D, Clay LJ, Field JJ, Kanter J, Cohen AJ, Saif Ur Rehman S, Lanzkron S, Little JA, GRNDaD investigators) Br J Haematol 2021 Dec;195(5):e157-e160 7 Citations |
| 1 | Socioeconomic Disparities and Risk Factors in Patients Presenting With Ischemic Priapism: A Multi-Institutional Study. (Patel PM, Slovacek H, Pahouja G, Patel HD, Cao D, Emerson J, Kansal J, Prebay Z, Medairos R, Doolittle J, Bresler L, Levine LA, Guise A, Bajic P) Urology 2022 May;163:50-55 5 Citations |
| 1 | A polygenic score for acute vaso-occlusive pain in pediatric sickle cell disease. (Rampersaud E, Kang G, Palmer LE, Rashkin SR, Wang S, Bi W, Alberts NM, Anghelescu D, Barton M, Birch K, Boulos N, Brandow AM, Brooke RJ, Chang TC, Chen W, Cheng Y, Ding J, Easton J, Hodges JR, Kanne CK, Levy S, Mulder H, Patel AP, Puri L, Rosencrance C, Rusch M, Sapkota Y, Sioson E, Sharma A, Tang X, Thrasher A, Wang W, Yao Y, Yasui Y, Yergeau D, Hankins JS, Sheehan VA, Downing JR, Estepp JH, Zhang J, DeBaun M, Wu G, Weiss MJ) Blood Adv 2021 Jul 27;5(14):2839-2851 17 Citations |
| 1 | Treatment of Acute Pain in Adults With Sickle Cell Disease in an Infusion Center Versus the Emergency Department : A Multicenter Prospective Cohort Study. (Lanzkron S, Little J, Wang H, Field JJ, Shows JR, Haywood C Jr, Saheed M, Proudford M, Robertson D, Kincaid A, Burgess L, Green C, Seufert R, Brooks J, Piehet A, Griffin B, Arnold N, Frymark S, Wallace M, Abu Al Hamayel N, Huang CY, Segal JB, Varadhan R) Ann Intern Med 2021 Sep;174(9):1207-1213 15 Citations |
| 1 | Fostering equity in education and academic outcomes in children with sickle cell disease. (Miller M, Landsman R, Scott JP, Heffelfinger AK) Clin Neuropsychol 2022 Feb;36(2):245-263 4 Citations |
| 3 | Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease. (Mucalo L, Brandow AM, Dasgupta M, Mason SF, Simpson PM, Singh A, Taylor BW, Woods KJ, Yusuf FI, Panepinto JA) Blood Adv 2021 Jul 13;5(13):2717-2724 45 Citations |
| 2 | The sickle erythrocyte yields another DAMP. (Rarick KR, Pritchard KA) Blood 2021 Jun 03;137(22):3010-3011 1 Citation |
| 1 | Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantation. (Friedman D, Dozor AJ, Milner J, D'Souza M, Talano JA, Moore TB, Shenoy S, Shi Q, Walters MC, Vichinsky E, Parsons SK, Braniecki S, Moorthy CR, Ayello J, Flower A, Morris E, Mahanti H, Fabricatore S, Klejmont L, van de Ven C, Baxter-Lowe LA, Cairo MS) Bone Marrow Transplant 2021 Sep;56(9):2221-2230 15 Citations |
| 2 | Hematopoietic Cell Transplantation Outcomes among Medicaid and Privately Insured Patients with Sickle Cell Disease. (Mupfudze TG, Meyer C, Preussler JM, Mau LW, Bolon YT, Steinert P, Arnold SD, Saber W, Krishnamurti L) Transplant Cell Ther 2021 Aug;27(8):685.e1-685.e8 4 Citations |
| 1 | Genetic therapies for the first molecular disease. (Doerfler PA, Sharma A, Porter JS, Zheng Y, Tisdale JF, Weiss MJ) J Clin Invest 2021 Apr 15;131(8) 21 Citations |
| 1 | Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing. (Leibowitz ML, Papathanasiou S, Doerfler PA, Blaine LJ, Sun L, Yao Y, Zhang CZ, Weiss MJ, Pellman D) Nat Genet 2021 Jun;53(6):895-905 341 Citations |
| 2 | COVID-19 in individuals with sickle cell disease/trait compared with other Black individuals. (Singh A, Brandow AM, Panepinto JA) Blood Adv 2021 Apr 13;5(7):1915-1921 56 Citations |
| 1 | Implementation of Individualized Pain Care Plans Decreases Length of Stay and Hospital Admission Rates for High Utilizing Adults with Sickle Cell Disease. (Welch-Coltrane JL, Wachnik AA, Adams MCB, Avants CR, Blumstein HA, Brooks AK, Farland AM, Johnson JB, Pariyadath M, Summers EC, Hurley RW) Pain Med 2021 Aug 06;22(8):1743-1752 11 Citations |
| 1 | Characterization and statistical modeling of glycosylation changes in sickle cell disease. (Ashwood HE, Ashwood C, Schmidt AP, Gundry RL, Hoffmeister KM, Anani WQ) Blood Adv 2021 Mar 09;5(5):1463-1473 7 Citations |
| 2 | Recommendation to reality: Closing the transcranial Doppler screening gap for children with sickle cell anemia. (Singh A, Danda V, Van Swol L, Scott JP, Brandow AM, Panepinto JA) Pediatr Blood Cancer 2021 Feb;68(2):e28831 5 Citations |
| 1 | Neuropathic pain in sickle cell disease: measurement and management. (Glaros A, Brandow AM) Hematology Am Soc Hematol Educ Program 2020 Dec 04;2020(1):553-561 5 Citations |
| 1 | Evidence for complement-mediated bone marrow necrosis in a young adult with sickle cell disease. (Azul M, Shah S, Williams S, Vercellotti GM, Boucher AA) Blood Cells Mol Dis 2021 Feb;86:102508 3 Citations |
| 2 | Neuropathic pain is associated with poor health-related quality of life in adolescents with sickle cell disease: A preliminary report. (Román ME, Highland J, Retherford D, Pan AY, Panepinto JA, Brandow AM) Pediatr Blood Cancer 2020 Dec;67(12):e28698 11 Citations |
| 2 | Coronavirus Disease among Persons with Sickle Cell Disease, United States, March 20-May 21, 2020. (Panepinto JA, Brandow A, Mucalo L, Yusuf F, Singh A, Taylor B, Woods K, Payne AB, Peacock G, Schieve LA) Emerg Infect Dis 2020 Oct;26(10):2473-2476 90 Citations |
| 1 | PARACENTRAL ACUTE MIDDLE MACULOPATHY AS A PRESENTING SIGN OF CENTRAL RETINAL ARTERY OCCLUSION IN SICKLE CELL DISEASE TREATED WITH TISSUE PLASMINOGEN ACTIVATOR. (Chua MR, Giovinazzo JV, Kaplan RI, Connor T, Kellner C, Barash A, Rosen RB) Retin Cases Brief Rep 2022 Sep 01;16(5):553-557 2 Citations |
| 2 | American Society of Hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. (Brandow AM, Carroll CP, Creary S, Edwards-Elliott R, Glassberg J, Hurley RW, Kutlar A, Seisa M, Stinson J, Strouse JJ, Yusuf F, Zempsky W, Lang E) Blood Adv 2020 Jun 23;4(12):2656-2701 224 Citations |
| 2 | Risk score to predict event-free survival after hematopoietic cell transplant for sickle cell disease. (Brazauskas R, Scigliuolo GM, Wang HL, Cappelli B, Ruggeri A, Fitzhugh CD, Hankins JS, Kanter J, Meerpohl JJ, Panepinto JA, Rondelli D, Shenoy S, Walters MC, Wagner JE, Tisdale JF, Gluckman E, Eapen M) Blood 2020 Jul 30;136(5):623-626 28 Citations |
| 2 | Teaching Versus Nonteaching Hospitals: Where Children With Sickle Cell Disease Receive Their Emergency Department Care. (Brousseau DC, Muslu CS, Visotcky A, Fraser R, Kavanagh PL, Chelius TH, Schuh AM) J Pediatr Hematol Oncol 2020 Aug;42(6):412-413 1 Citation |
| 1 | Can PROMIS domains of pain and physical functioning detect changes in health over time for children with sickle cell disease? (Singh A, Dasgupta M, Simpson PM, Brousseau DC, Panepinto JA) Pediatr Blood Cancer 2020 May;67(5):e28203 7 Citations |
| 1 | Hyperuricemia is associated with a lower glomerular filtration rate in pediatric sickle cell disease patients. (Kaspar CDW, Beach I, Newlin J, Sisler I, Feig D, Smith W) Pediatr Nephrol 2020 May;35(5):883-889 10 Citations |
| 3 | Social and Psychological Factors Associated With Health Care Transition for Young Adults Living With Sickle Cell Disease. (Clayton-Jones D, Matthie N, Treadwell M, Field JJ, Mager A, Sawdy R, George Dalmida S, Leonard C, Koch KL, Haglund K) J Transcult Nurs 2021 Jan;32(1):21-29 10 Citations |
| 1 | End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain. (Farrell AT, Panepinto J, Carroll CP, Darbari DS, Desai AA, King AA, Adams RJ, Barber TD, Brandow AM, DeBaun MR, Donahue MJ, Gupta K, Hankins JS, Kameka M, Kirkham FJ, Luksenburg H, Miller S, Oneal PA, Rees DC, Setse R, Sheehan VA, Strouse J, Stucky CL, Werner EM, Wood JC, Zempsky WT) Blood Adv 2019 Dec 10;3(23):3982-4001 50 Citations |
| 1 | Genome editing of HBG1 and HBG2 to induce fetal hemoglobin. (Métais JY, Doerfler PA, Mayuranathan T, Bauer DE, Fowler SC, Hsieh MM, Katta V, Keriwala S, Lazzarotto CR, Luk K, Neel MD, Perry SS, Peters ST, Porter SN, Ryu BY, Sharma A, Shea D, Tisdale JF, Uchida N, Wolfe SA, Woodard KJ, Wu Y, Yao Y, Zeng J, Pruett-Miller S, Tsai SQ, Weiss MJ) Blood Adv 2019 Nov 12;3(21):3379-3392 127 Citations |
| 1 | The controversial role of red cell transfusions for sickle cell pain. (Karafin MS, Field JJ) Curr Opin Hematol 2019 Nov;26(6):442-447 1 Citation |
| 2 | Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study. (Eapen M, Brazauskas R, Walters MC, Bernaudin F, Bo-Subait K, Fitzhugh CD, Hankins JS, Kanter J, Meerpohl JJ, Bolaños-Meade J, Panepinto JA, Rondelli D, Shenoy S, Williamson J, Woolford TL, Gluckman E, Wagner JE, Tisdale JF) Lancet Haematol 2019 Nov;6(11):e585-e596 143 Citations |
| 1 | Identifying Clinical and Research Priorities in Sickle Cell Lung Disease. An Official American Thoracic Society Workshop Report. (Ruhl AP, Sadreameli SC, Allen JL, Bennett DP, Campbell AD, Coates TD, Diallo DA, Field JJ, Fiorino EK, Gladwin MT, Glassberg JA, Gordeuk VR, Graham LM, Greenough A, Howard J, Kato GJ, Knight-Madden J, Kopp BT, Koumbourlis AC, Lanzkron SM, Liem RI, Machado RF, Mehari A, Morris CR, Ogunlesi FO, Rosen CL, Smith-Whitley K, Tauber D, Terry N, Thein SL, Vichinsky E, Weir NA, Cohen RT, Klings ES) Ann Am Thorac Soc 2019 Sep;16(9):e17-e32 39 Citations |
| 1 | Neuropathic pain in individuals with sickle cell disease. (Sharma D, Brandow AM) Neurosci Lett 2020 Jan 01;714:134445 19 Citations |
| 1 | Clinical meaning of PROMIS pain domains for children with sickle cell disease. (Singh A, Panepinto JA) Blood Adv 2019 Aug 13;3(15):2244-2249 16 Citations |
| 2 | Challenges in clinical implementation of CYP2D6 genotyping: choice of variants to test affects phenotype determination. (Hoshitsuki K, Crews KR, Yang W, Smith CA, Hankins JS, Turner AJ, Broeckel U, McMillin GA, Relling MV, Haidar CE) Genet Med 2020 Jan;22(1):232-233 8 Citations |
| 1 | Foveal avascular zone morphology and parafoveal capillary perfusion in sickle cell retinopathy. (Lynch G, Scott AW, Linz MO, Han I, Andrade Romo JS, Linderman RE, Carroll J, Rosen RB, Chui TY) Br J Ophthalmol 2020 Apr;104(4):473-479 24 Citations |
| 1 | Chronic pain persists in adults with sickle cell disease despite regular red cell transfusions. (Karafin MS, Mullins DE, Johnson ST, Nischik D, Feng M, Simpson P, Field JJ) Transfus Apher Sci 2019 Aug;58(4):434-438 9 Citations |
| 1 | Interventions for treating neuropathic pain in people with sickle cell disease. (Asnani MR, Francis DK, Brandow AM, Hammond Gabbadon CE, Ali A) Cochrane Database Syst Rev 2019 Jul 05;7(7):CD012943 2 Citations |
| 1 | Contrast-enhanced ultrasound detects changes in microvascular blood flow in adults with sickle cell disease. (Lindner JR, Belcik T, Widlansky M, Harmann LM, Karafin MS, Wandersee NJ, Puligandla M, Neuberg D, Linden J, Field JJ) PLoS One 2019;14(7):e0218783 9 Citations |
| 2 | Gabapentin alleviates chronic spontaneous pain and acute hypoxia-related pain in a mouse model of sickle cell disease. (Sadler KE, Langer SN, Menzel AD, Moehring F, Erb AN, Brandow AM, Stucky CL) Br J Haematol 2019 Oct;187(2):246-260 12 Citations |
| 3 | Longitudinal Trend in Emergency Department Reliance for Pain Among Sickle Cell Disease Patients in Wisconsin. (Singh A, Yan K, Brandow AM, Panepinto JA) J Pediatr Hematol Oncol 2019 Oct;41(7):e438-e442 6 Citations |
| 4 | Chronic pain in adults with sickle cell disease is associated with alterations in functional connectivity of the brain. (Karafin MS, Chen G, Wandersee NJ, Brandow AM, Hurley RW, Simpson P, Ward D, Li SJ, Field JJ) PLoS One 2019;14(5):e0216994 20 Citations |
| 1 | Blocking COX-2 for sickle cell pain relief. (Sadler KE, Stucky CL) Blood 2019 May 02;133(18):1924-1925 4 Citations |
| 1 | Effect of Sickle Cell Anemia Therapies on the Natural History of Growth and Puberty Patterns. (Nagalapuram V, Kulkarni V, Leach J, Aban I, Sirigaddi K, Lebensburger JD, Iyer P) J Pediatr Hematol Oncol 2019 Nov;41(8):606-611 1 Citation |
| 1 | Hydroxyurea reduces cerebral metabolic stress in patients with sickle cell anemia. (Fields ME, Guilliams KP, Ragan D, Binkley MM, Mirro A, Fellah S, Hulbert ML, Blinder M, Eldeniz C, Vo K, Shimony JS, Chen Y, McKinstry RC, An H, Lee JM, Ford AL) Blood 2019 May 30;133(22):2436-2444 48 Citations |
| 1 | Use of the new pediatric PROMIS measures of pain and physical experiences for children with sickle cell disease. (Singh A, DasGupta M, Simpson PM, Panepinto JA) Pediatr Blood Cancer 2019 May;66(5):e27633 32 Citations |
| 1 | Functional and Radiologic Assessment of the Brain after Reduced-Intensity Unrelated Donor Transplantation for Severe Sickle Cell Disease: Blood and Marrow Transplant Clinical Trials Network Study 0601. (King AA, McKinstry RC, Wu J, Eapen M, Abel R, Varughese T, Kamani N, Shenoy S) Biol Blood Marrow Transplant 2019 May;25(5):e174-e178 22 Citations |
| 1 | Use of the Spiritual Development Framework in Conducting Spirituality and Health Research with Adolescents. (Clayton-Jones D, Haglund KA, Schaefer J, Koenig HG, George Dalmida S) J Relig Health 2019 Aug;58(4):1259-1271 4 Citations |
| 1 | AAAPT Diagnostic Criteria for Acute Sickle Cell Disease Pain. (Field JJ, Ballas SK, Campbell CM, Crosby LE, Dampier C, Darbari DS, McClish DK, Smith WR, Zempsky WT) J Pain 2019 Jul;20(7):746-759 38 Citations |
| 1 | Neuronal transient receptor potential (TRP) channels and noxious sensory detection in sickle cell disease. (Sadler KE, Stucky CL) Neurosci Lett 2019 Feb 16;694:184-191 13 Citations |
| 1 | Integration of neuropsychology services in a sickle cell clinic and subsequent healthcare use for pain crises. (Janecek JK, Dorociak KE, Piper LE, Kelleher T, Pliskin NH, Gowhari M, Molokie RE) Clin Neuropsychol 2019 Oct;33(7):1195-1211 10 Citations |
| 1 | Content validity of the PROMIS® pediatric family relationships measure for children with chronic illness. (Flynn KE, Kliems H, Saoji N, Svenson J, Cox ED) Health Qual Life Outcomes 2018 Oct 19;16(1):203 3 Citations |
| 2 | Children and adolescents with sickle cell disease have worse cold and mechanical hypersensitivity during acute painful events. (Brandow AM, Hansen K, Nugent M, Pan A, Panepinto JA, Stucky CL) Pain 2019 Feb;160(2):407-416 21 Citations |
| 1 | The clinical impact of glucose-6-phosphate dehydrogenase deficiency in patients with sickle cell disease. (Karafin MS, Fu X, D'Alessandro A, Thomas T, Hod EA, Zimring JC, Field JJ, Francis RO) Curr Opin Hematol 2018 Nov;25(6):494-499 14 Citations |
| 1 | Red blood cell exchange in patients with sickle cell disease-indications and management: a review and consensus report by the therapeutic apheresis subsection of the AABB. (Biller E, Zhao Y, Berg M, Boggio L, Capocelli KE, Fang DC, Koepsell S, Music-Aplenc L, Pham HP, Treml A, Weiss J, Wool G, Baron BW) Transfusion 2018 Aug;58(8):1965-1972 36 Citations |
| 1 | Induction of antiinflammatory purinergic signaling in activated human iNKT cells. (Yu JC, Lin G, Field JJ, Linden J) JCI Insight 2018 Sep 06;3(17) 14 Citations |
| 1 | Silent infarcts in sickle cell disease occur in the border zone region and are associated with low cerebral blood flow. (Ford AL, Ragan DK, Fellah S, Binkley MM, Fields ME, Guilliams KP, An H, Jordan LC, McKinstry RC, Lee JM, DeBaun MR) Blood 2018 Oct 18;132(16):1714-1723 93 Citations |
| 1 | Practice Variation in Emergency Department Management of Children With Sickle Cell Disease Who Present With Fever. (Eisenbrown K, Ellison AM, Nimmer M, Badaki-Makun O, Brousseau DC) Pediatr Emerg Care 2018 Aug;34(8):574-577 6 Citations |
| 3 | Predictive factors of daily opioid use and quality of life in adults with sickle cell disease. (Karafin MS, Singavi A, Hussain J, Wandersee N, Heinrich T, Hurley RW, Zhang L, Simpson P, Field JJ) Hematology 2018 Dec;23(10):856-863 24 Citations |
| 1 | A method for age-matched OCT angiography deviation mapping in the assessment of disease- related changes to the radial peripapillary capillaries. (Pinhas A, Linderman R, Mo S, Krawitz BD, Geyman LS, Carroll J, Rosen RB, Chui TY) PLoS One 2018;13(5):e0197062 27 Citations |
| 1 | Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood. (Hankins JS, Estepp JH, Hodges JR, Villavicencio MA, Robison LL, Weiss MJ, Kang G, Schreiber JE, Porter JS, Kaste SC, Saving KL, Bryant PC, Deyo JE, Nottage KA, King AA, Brandow AM, Lebensburger JD, Adesina O, Chou ST, Zemel BS, Smeltzer MP, Wang WC, Gurney JG) Pediatr Blood Cancer 2018 Sep;65(9):e27228 62 Citations |
| 1 | Key Components of Pain Management for Children and Adults with Sickle Cell Disease. (Brandow AM, DeBaun MR) Hematol Oncol Clin North Am 2018 Jun;32(3):535-550 42 Citations |
| 1 | Chemokine (c-c motif) receptor 2 mediates mechanical and cold hypersensitivity in sickle cell disease mice. (Sadler KE, Zappia KJ, O'Hara CL, Langer SN, Weyer AD, Hillery CA, Stucky CL) Pain 2018 Aug;159(8):1652-1663 25 Citations |
| 1 | Common α-globin variants modify hematologic and other clinical phenotypes in sickle cell trait and disease. (Raffield LM, Ulirsch JC, Naik RP, Lessard S, Handsaker RE, Jain D, Kang HM, Pankratz N, Auer PL, Bao EL, Smith JD, Lange LA, Lange EM, Li Y, Thornton TA, Young BA, Abecasis GR, Laurie CC, Nickerson DA, McCarroll SA, Correa A, Wilson JG, NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium, Hematology & Hemostasis, Diabetes, and Structural Variation TOPMed Working Groups, Lettre G, Sankaran VG, Reiner AP) PLoS Genet 2018 Mar;14(3):e1007293 43 Citations |
| 1 | Regional oxygen extraction predicts border zone vulnerability to stroke in sickle cell disease. (Fields ME, Guilliams KP, Ragan DK, Binkley MM, Eldeniz C, Chen Y, Hulbert ML, McKinstry RC, Shimony JS, Vo KD, Doctor A, An H, Ford AL, Lee JM) Neurology 2018 Mar 27;90(13):e1134-e1142 86 Citations |
| 2 | Youth Victims of Violence Report Worse Quality of Life Than Youth With Chronic Diseases. (Levas MN, Melzer-Lange M, Tarima S, Beverung LM, Panepinto J) Pediatr Emerg Care 2020 Feb;36(2):e72-e78 3 Citations |
| 2 | Dyspareunia is associated with chronic pain in premenopausal women with sickle cell disease. (Karafin MS, Singh M, Ceesay M, Koduri S, Zhang L, Simpson P, Field JJ) Hematology 2018 Sep;23(8):531-536 7 Citations |
| 1 | Red cell exchange transfusions lower cerebral blood flow and oxygen extraction fraction in pediatric sickle cell anemia. (Guilliams KP, Fields ME, Ragan DK, Eldeniz C, Binkley MM, Chen Y, Comiskey LS, Doctor A, Hulbert ML, Shimony JS, Vo KD, McKinstry RC, An H, Lee JM, Ford AL) Blood 2018 Mar 01;131(9):1012-1021 75 Citations |
| 1 | Parents' pain medication underdosing is associated with more emergency department visits in sickle cell disease. (Morrison AK, Myrvik MP, Brousseau DC, Drendel AL, Scott JP, Visotcky A, Panepinto JA) Pediatr Blood Cancer 2018 Apr;65(4) 15 Citations |
| 1 | Pain-measurement tools in sickle cell disease: where are we now? (Darbari DS, Brandow AM) Hematology Am Soc Hematol Educ Program 2017 Dec 08;2017(1):534-541 26 Citations |
| 1 | Five lessons learned about long-term pain management in adults with sickle cell disease. (Field JJ) Hematology Am Soc Hematol Educ Program 2017 Dec 08;2017(1):406-411 16 Citations |
| 1 | Responsiveness of Patient-Reported Outcome Measurement Information System (PROMIS) pain domains and disease-specific patient-reported outcome measures in children and adults with sickle cell disease. (Curtis S, Brandow AM) Hematology Am Soc Hematol Educ Program 2017 Dec 08;2017(1):542-545 9 Citations |
| 1 | Relationship between Mixed Donor-Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease. (Abraham A, Hsieh M, Eapen M, Fitzhugh C, Carreras J, Keesler D, Guilcher G, Kamani N, Walters MC, Boelens JJ, Tisdale J, Shenoy S, National Institutes of Health, Center for International Blood and Marrow Transplant Research) Biol Blood Marrow Transplant 2017 Dec;23(12):2178-2183 81 Citations |
| 1 | Opioid management strategy decreases admissions in high-utilizing adults with sickle cell disease. (Mager A, Pelot K, Koch K, Miller L, Hubler C, Ndifor A, Coan C, Leonard C, Field JJ) J Opioid Manag 2017;13(3):143-156 20 Citations |
| 2 | Clinical risks and healthcare utilization of hematopoietic cell transplantation for sickle cell disease in the USA using merged databases. (Arnold SD, Brazauskas R, He N, Li Y, Aplenc R, Jin Z, Hall M, Atsuta Y, Dalal J, Hahn T, Khera N, Bonfim C, Majhail NS, Diaz MA, Freytes CO, Wood WA, Savani BN, Kamble RT, Parsons S, Ahmed I, Sullivan K, Beattie S, Dandoy C, Munker R, Marino S, Bitan M, Abdel-Azim H, Aljurf M, Olsson RF, Joshi S, Buchbinder D, Eckrich MJ, Hashmi S, Lazarus H, Marks DI, Steinberg A, Saad A, Gergis U, Krishnamurti L, Abraham A, Rangarajan HG, Walters M, Lipscomb J, Saber W, Satwani P) Haematologica 2017 Nov;102(11):1823-1832 44 Citations |
| 1 | Performance validity testing in a clinical sample of adults with sickle cell disease. (Dorociak KE, Schulze ET, Piper LE, Molokie RE, Janecek JK) Clin Neuropsychol 2018 Jan;32(1):81-97 16 Citations |
| 1 | Airway Hyperresponsiveness Does Not Predict Morbidity in Children with Sickle Cell Anemia. (Willen SM, Rodeghier M, Strunk RC, Rosen CL, Kirkham FJ, Field JJ, DeBaun MR, Cohen RT) Am J Respir Crit Care Med 2017 Jun 01;195(11):1533-1534 5 Citations |
| 2 | Older red cell units are associated with an increased incidence of infection in chronically transfused adults with sickle cell disease. (Karafin MS, Carpenter E, Pan A, Simpson P, Field JJ) Transfus Apher Sci 2017 Jun;56(3):345-351 8 Citations |
| 2 | Sickle cell disease: a natural model of acute and chronic pain. (Brandow AM, Zappia KJ, Stucky CL) Pain 2017 Apr;158 Suppl 1(Suppl 1):S79-S84 48 Citations |
| 1 | Large-Vessel Vasculopathy in Children With Sickle Cell Disease: A Magnetic Resonance Imaging Study of Infarct Topography and Focal Atrophy. (Guilliams KP, Fields ME, Ragan DK, Chen Y, Eldeniz C, Hulbert ML, Binkley MM, Rhodes JN, Shimony JS, McKinstry RC, Vo KD, An H, Lee JM, Ford AL) Pediatr Neurol 2017 Apr;69:49-57 41 Citations |
| 1 | NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease. (Field JJ, Majerus E, Ataga KI, Vichinsky EP, Schaub R, Mashal R, Nathan DG) PLoS One 2017;12(2):e0171067 26 Citations |
| 1 | Identification and Validation of a Sickle Cell Disease Cohort Within Electronic Health Records. (Michalik DE, Taylor BW, Panepinto JA) Acad Pediatr 2017 Apr;17(3):283-287 23 Citations |
| 1 | Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation. (Gluckman E, Cappelli B, Bernaudin F, Labopin M, Volt F, Carreras J, Pinto Simões B, Ferster A, Dupont S, de la Fuente J, Dalle JH, Zecca M, Walters MC, Krishnamurti L, Bhatia M, Leung K, Yanik G, Kurtzberg J, Dhedin N, Kuentz M, Michel G, Apperley J, Lutz P, Neven B, Bertrand Y, Vannier JP, Ayas M, Cavazzana M, Matthes-Martin S, Rocha V, Elayoubi H, Kenzey C, Bader P, Locatelli F, Ruggeri A, Eapen M, Eurocord, the Pediatric Working Party of the European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research) Blood 2017 Mar 16;129(11):1548-1556 366 Citations |
| 2 | Which Febrile Children With Sickle Cell Disease Need a Chest X-Ray? (Eisenbrown K, Nimmer M, Ellison AM, Simpson P, Brousseau DC) Acad Emerg Med 2016 Nov;23(11):1248-1256 7 Citations |
| 3 | A trial of unrelated donor marrow transplantation for children with severe sickle cell disease. (Shenoy S, Eapen M, Panepinto JA, Logan BR, Wu J, Abraham A, Brochstein J, Chaudhury S, Godder K, Haight AE, Kasow KA, Leung K, Andreansky M, Bhatia M, Dalal J, Haines H, Jaroscak J, Lazarus HM, Levine JE, Krishnamurti L, Margolis D, Megason GC, Yu LC, Pulsipher MA, Gersten I, DiFronzo N, Horowitz MM, Walters MC, Kamani N) Blood 2016 Nov 24;128(21):2561-2567 164 Citations |
| 2 | Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use. (Brandow AM, Wandersee NJ, Dasgupta M, Hoffmann RG, Hillery CA, Stucky CL, Panepinto JA) Br J Haematol 2016 Oct;175(2):237-245 32 Citations |
| 1 | Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease. (Brandow AM, Nimmer M, Simmons T, Charles Casper T, Cook LJ, Chumpitazi CE, Paul Scott J, Panepinto JA, Brousseau DC) Am J Hematol 2016 Dec;91(12):1175-1180 22 Citations |
| 1 | Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease. (Gammal RS, Crews KR, Haidar CE, Hoffman JM, Baker DK, Barker PJ, Estepp JH, Pei D, Broeckel U, Wang W, Weiss MJ, Relling MV, Hankins J) Pediatrics 2016 Jul;138(1) 86 Citations |
| 1 | Clinical Interpretation of Quantitative Sensory Testing as a Measure of Pain Sensitivity in Patients With Sickle Cell Disease. (Brandow AM, Panepinto JA) J Pediatr Hematol Oncol 2016 May;38(4):288-93 32 Citations |
| 1 | Spirituality and Religiosity in Adolescents Living With Sickle Cell Disease. (Clayton-Jones D, Haglund K, Belknap RA, Schaefer J, Thompson AA) West J Nurs Res 2016 Jun;38(6):686-703 25 Citations |
| 2 | Maternal opioid dose is associated with neonatal abstinence syndrome in children born to women with sickle cell disease. (Shirel T, Hubler CP, Shah R, Mager AB, Koch KL, Sheth D, Uhing MR, Jones CW, Field JJ) Am J Hematol 2016 Jun;91(4):416-9 14 Citations |
| 3 | Red cell storage age policy for patients with sickle cell disease: A survey of transfusion service directors in the United States. (Karafin MS, Singavi AK, Irani MS, Puca KE, Baumann Kreuziger L, Simpson P, Field JJ) Transfus Apher Sci 2016 Feb;54(1):158-62 4 Citations |
| 1 | Sickle solubility test to screen for sickle cell trait: what's the harm? (Tubman VN, Field JJ) Hematology Am Soc Hematol Educ Program 2015;2015:433-5 9 Citations |
| 1 | Can selectin and iNKT cell therapies meet the needs of people with sickle cell disease? (Field JJ) Hematology Am Soc Hematol Educ Program 2015;2015:426-32 5 Citations |
| 1 | The Role of Spirituality and Religiosity in Persons Living With Sickle Cell Disease: A Review of the Literature. (Clayton-Jones D, Haglund K) J Holist Nurs 2016 Dec;34(4):351-360 26 Citations |
| 3 | Erythropoietic drive is the strongest predictor of hepcidin level in adults with sickle cell disease. (Karafin MS, Koch KL, Rankin AB, Nischik D, Rahhal G, Simpson P, Field JJ) Blood Cells Mol Dis 2015 Dec;55(4):304-7 19 Citations |
| 1 | Curative treatment for severe sickle cell disease: allogeneic transplantation. (Oshrine B, Talano JA) Clin Adv Hematol Oncol 2015 Apr;13(4):249-56 4 Citations |
| 1 | Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia. (Estepp JH, Melloni C, Thornburg CD, Wiczling P, Rogers Z, Rothman JA, Green NS, Liem R, Brandow AM, Crary SE, Howard TH, Morris MH, Lewandowski A, Garg U, Jusko WJ, Neville KA, Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee) J Clin Pharmacol 2016 Mar;56(3):298-306 18 Citations |
| 1 | Increased circulating fibrocytes are associated with higher reticulocyte percent in children with sickle cell anemia. (Karafin MS, Dogra S, Rodeghier M, Burdick M, Mehrad B, Rose CE, Strieter RM, DeBaun MR, Strunk RC, Field JJ) Pediatr Pulmonol 2016 Mar;51(3):295-9 2 Citations |
| 1 | Early insights into the neurobiology of pain in sickle cell disease: A systematic review of the literature. (Brandow AM, Farley RA, Panepinto JA) Pediatr Blood Cancer 2015 Sep;62(9):1501-11 51 Citations |
| 1 | NHLBI state of the science symposium in therapeutic apheresis: Knowledge gaps and research opportunities in the area of hematology-oncology. (Karafin MS, Sachais BS, Connelly-Smith L, Field JJ, Linenberger ML, Padmanabhan A) J Clin Apher 2016 Feb;31(1):38-47 6 Citations |
| 3 | Use of a dual lumen port for automated red cell exchange in adults with sickle cell disease. (Shrestha A, Jawa Z, Koch KL, Rankin AB, Xiang Q, Padmanabhan A, Karafin MS, Field JJ) J Clin Apher 2015 Dec;30(6):353-8 29 Citations |
| 1 | Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease. (Karafin MS, Field JJ, Gottschall JL, Denomme GA) Transfusion 2015 Jun;55(6 Pt 2):1399-406 26 Citations |
| 1 | Smoothing the crescent curve: sickle cell disease. (Talano JA, Cairo MS) Hematology Am Soc Hematol Educ Program 2014 Dec 05;2014(1):468-74 7 Citations |
| 1 | The accuracy of using ICD-9-CM codes to determine genotype and fever status of patients with sickle cell disease. (Eisenbrown K, Nimmer M, Brousseau DC) Pediatr Blood Cancer 2015 May;62(5):924-5 13 Citations |
| 3 | A Comparison of Pain Assessment Measures in Pediatric Sickle Cell Disease: Visual Analog Scale Versus Numeric Rating Scale. (Myrvik MP, Drendel AL, Brandow AM, Yan K, Hoffmann RG, Panepinto JA) J Pediatr Hematol Oncol 2015 Apr;37(3):190-4 25 Citations |
| 1 | Advances in sickle cell therapies in the hydroxyurea era. (Field JJ, Nathan DG) Mol Med 2014 Dec 16;20 Suppl 1(Suppl 1):S37-42 16 Citations |
| 1 | Dietary supplementation with docosahexanoic acid (DHA) increases red blood cell membrane flexibility in mice with sickle cell disease. (Wandersee NJ, Maciaszek JL, Giger KM, Hanson MS, Zheng S, Guo Y, Mickelson B, Hillery CA, Lykotrafitis G, Low PS, Hogg N) Blood Cells Mol Dis 2015 Feb;54(2):183-8 26 Citations |
| 1 | Five hematologic tests and treatments to question. (Hicks LK, Bering H, Carson KR, Haynes AE, Kleinerman J, Kukreti V, Ma A, Mueller BU, O'Brien SH, Panepinto JA, Pasquini MC, Rajasekhar A, Sarode R, Wood WA) Blood 2014 Dec 04;124(24):3524-8 47 Citations |
| 3 | Intensive management of high-utilizing adults with sickle cell disease lowers admissions. (Koch KL, Karafin MS, Simpson P, Field JJ) Am J Hematol 2015 Mar;90(3):215-9 27 Citations |
| 3 | Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammation. (Xu H, Wandersee NJ, Guo Y, Jones DW, Holzhauer SL, Hanson MS, Machogu E, Brousseau DC, Hogg N, Densmore JC, Kaul S, Hillery CA, Pritchard KA Jr) Blood 2014 Dec 18;124(26):3978-81 45 Citations |
| 1 | Update on the use of hydroxyurea therapy in sickle cell disease. (Wong TE, Brandow AM, Lim W, Lottenberg R) Blood 2014 Dec 18;124(26):3850-7; quiz 4004 82 Citations |
| 1 | The use of neuropathic pain drugs in children with sickle cell disease is associated with older age, female sex, and longer length of hospital stay. (Brandow AM, Farley RA, Dasgupta M, Hoffmann RG, Panepinto JA) J Pediatr Hematol Oncol 2015 Jan;37(1):10-5 26 Citations |
| 1 | Hematopoietic stem cell transplantation for sickle cell disease: state of the science. (Talano JA, Cairo MS) Eur J Haematol 2015 May;94(5):391-9 29 Citations |
| 1 | Cold hypersensitivity increases with age in mice with sickle cell disease. (Zappia KJ, Garrison SR, Hillery CA, Stucky CL) Pain 2014 Dec;155(12):2476-2485 54 Citations |
| 1 | Sickle cell disease: new treatments and their rationale. (Field JJ) Clin Adv Hematol Oncol 2013 Nov;11(11):740-3 1 Citation |
| 1 | Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell disease. (Ataga KI, Hinderliter A, Brittain JE, Jones S, Xu H, Cai J, Kim S, Pritchard KA, Hillery CA) Hematology 2015 Jun;20(5):289-96 11 Citations |
| 1 | Ambulatory quality indicators to prevent infection in sickle cell disease. (Beverung LM, Brousseau D, Hoffmann RG, Yan K, Panepinto JA) Am J Hematol 2014 Mar;89(3):256-60 38 Citations |
| 1 | Do difficulties in swallowing medication impede the use of hydroxyurea in children? (Bekele E, Thornburg CD, Brandow AM, Sharma M, Smaldone AM, Jin Z, Green NS) Pediatr Blood Cancer 2014 Sep;61(9):1536-9 18 Citations |
| 1 | Anion exchange HPLC isolation of high-density lipoprotein (HDL) and on-line estimation of proinflammatory HDL. (Ji X, Xu H, Zhang H, Hillery CA, Gao HQ, Pritchard KA Jr) PLoS One 2014;9(3):e91089 14 Citations |
| 1 | The role of adenosine signaling in sickle cell therapeutics. (Field JJ, Nathan DG, Linden J) Hematol Oncol Clin North Am 2014 Apr;28(2):287-99 23 Citations |
| 1 | Neuropathic pain in patients with sickle cell disease. (Brandow AM, Farley RA, Panepinto JA) Pediatr Blood Cancer 2014 Mar;61(3):512-7 77 Citations |
| 1 | NF-κB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induction of adenosine A2A receptors. (Lin G, Field JJ, Yu JC, Ken R, Neuberg D, Nathan DG, Linden J) PLoS One 2013;8(10):e74664 25 Citations |
| 3 | Inhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease mice. (Zhang H, Xu H, Weihrauch D, Jones DW, Jing X, Shi Y, Gourlay D, Oldham KT, Hillery CA, Pritchard KA Jr) J Lipid Res 2013 Nov;54(11):3009-15 37 Citations |
| 1 | Academic attainment findings in children with sickle cell disease. (Epping AS, Myrvik MP, Newby RF, Panepinto JA, Brandow AM, Scott JP) J Sch Health 2013 Aug;83(8):548-53 36 Citations |
| 3 | Clinically meaningful measurement of pain in children with sickle cell disease. (Myrvik MP, Brandow AM, Drendel AL, Yan K, Hoffmann RG, Panepinto JA) Pediatr Blood Cancer 2013 Oct;60(10):1689-95 33 Citations |
| 2 | Death during an asthma exacerbation in an adult with sickle cell disease: an autopsy case study. (Dhakal B, Giese K, Santo-Thomas L, Field JJ) Am J Hematol 2013 Sep;88(9):824 5 Citations |
| 1 | Environmental tobacco smoke and airway obstruction in children with sickle cell anemia. (Cohen RT, Strunk RC, Field JJ, Rosen CL, Kirkham FJ, Redline S, Stocks J, Rodeghier MJ, DeBaun MR) Chest 2013 Oct;144(4):1323-1329 18 Citations |
| 1 | Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents. (Omondi NA, Ferguson SE, Majhail NS, Denzen EM, Buchanan GR, Haight AE, Labotka RJ, Rizzo JD, Murphy EA) J Pediatr Hematol Oncol 2013 May;35(4):289-98 30 Citations |
| 1 | Red blood cell alloimmunization: lessons from sickle cell disease. (Treml A, King KE) Transfusion 2013 Apr;53(4):692-5 12 Citations |
| 1 | Assessment of communication modes in patients and families with sickle cell disease. (Anderson C, Torres S, Gokuli S, Brandow AM, Panepinto JA) Pediatr Blood Cancer 2013 May;60(5):887 2 Citations |
| 1 | Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson. (Field JJ, Lin G, Okam MM, Majerus E, Keefer J, Onyekwere O, Ross A, Campigotto F, Neuberg D, Linden J, Nathan DG) Blood 2013 Apr 25;121(17):3329-34 85 Citations |
| 1 | Improved survival among sickle cell kidney transplant recipients in the recent era. (Huang E, Parke C, Mehrnia A, Kamgar M, Pham PT, Danovitch G, Bunnapradist S) Nephrol Dial Transplant 2013 Apr;28(4):1039-46 41 Citations |
| 2 | A novel hemoglobin-binding peptide reduces cell-free hemoglobin in murine hemolytic anemia. (Hanson MS, Xu H, Flewelen TC, Holzhauer SL, Retherford D, Jones DW, Frei AC, Pritchard KA Jr, Hillery CA, Hogg N, Wandersee NJ) Am J Physiol Heart Circ Physiol 2013 Jan 15;304(2):H328-36 12 Citations |
| 2 | Patients with sickle cell disease have increased sensitivity to cold and heat. (Brandow AM, Stucky CL, Hillery CA, Hoffmann RG, Panepinto JA) Am J Hematol 2013 Jan;88(1):37-43 126 Citations |
| 1 | HCT for nonmalignant disorders. (Tisdale JF, Eapen M, Saccardi R) Biol Blood Marrow Transplant 2013 Jan;19(1 Suppl):S6-9 4 Citations |
| 2 | Sickle cell mice exhibit mechanical allodynia and enhanced responsiveness in light touch cutaneous mechanoreceptors. (Garrison SR, Kramer AA, Gerges NZ, Hillery CA, Stucky CL) Mol Pain 2012 Sep 10;8:62 45 Citations |
| 1 | Use of social support during communication about sickle cell carrier status. (Bradford L, Roedl SJ, Christopher SA, Farrell MH) Patient Educ Couns 2012 Aug;88(2):203-8 11 Citations |
| 1 | The role of fibrocytes in sickle cell lung disease. (Field JJ, Burdick MD, DeBaun MR, Strieter BA, Liu L, Mehrad B, Rose CE Jr, Linden J, Strieter RM) PLoS One 2012;7(3):e33702 21 Citations |
| 2 | Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). (Kamani NR, Walters MC, Carter S, Aquino V, Brochstein JA, Chaudhury S, Eapen M, Freed BM, Grimley M, Levine JE, Logan B, Moore T, Panepinto J, Parikh S, Pulsipher MA, Sande J, Schultz KR, Spellman S, Shenoy S) Biol Blood Marrow Transplant 2012 Aug;18(8):1265-72 169 Citations |
| 1 | Inpatient management of sickle cell pain: a 'snapshot' of current practice. (Miller ST, Kim HY, Weiner D, Wager CG, Gallagher D, Styles L, Dampier CD, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN)) Am J Hematol 2012 Mar;87(3):333-6 34 Citations |
| 1 | A method to assess the organizing behaviors used in physicians' counseling of standardized parents after newborn genetic screening. (Christopher SA, Ahmad NY, Bradford L, Collins JL, Eskra K, Kirschner Al, O'Tool FO, Roedl SJ, Farrell MH) Commun Med 2012;9(2):101-11 3 Citations |
| 1 | Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'. (Freed J, Talano J, Small T, Ricci A, Cairo MS) Bone Marrow Transplant 2012 Dec;47(12):1489-98 20 Citations |
| 1 | Clinical trial implementation and recruitment: lessons learned from the early closure of a randomized clinical trial. (Peters-Lawrence MH, Bell MC, Hsu LL, Osunkwo I, Seaman P, Blackwood M, Guillaume E, Bellevue R, Krishnamurti L, Smith WR, Dampier CD, Minniti CP, Sickle Cell Disease Clinical Research Network (SCDCRN)) Contemp Clin Trials 2012 Mar;33(2):291-7 52 Citations |
| 1 | Effects of experimental asthma on inflammation and lung mechanics in sickle cell mice. (Pritchard KA Jr, Feroah TR, Nandedkar SD, Holzhauer SL, Hutchins W, Schulte ML, Strunk RC, Debaun MR, Hillery CA) Am J Respir Cell Mol Biol 2012 Mar;46(3):389-96 25 Citations |
| 1 | Abnormalities in cardiac structure and function in adults with sickle cell disease are not associated with pulmonary hypertension. (Knight-Perry JE, de las Fuentes L, Waggoner AD, Hoffmann RG, Blinder MA, Dávila-Román VG, Field JJ) J Am Soc Echocardiogr 2011 Nov;24(11):1285-90 16 Citations |
| 1 | Monitoring toxicity, impact, and adherence of hydroxyurea in children with sickle cell disease. (Brandow AM, Panepinto JA) Am J Hematol 2011 Sep;86(9):804-6 28 Citations |
| 1 | When children with sickle-cell disease become adults: lack of outpatient care leads to increased use of the emergency department. (Hemker BG, Brousseau DC, Yan K, Hoffmann RG, Panepinto JA) Am J Hematol 2011 Oct;86(10):863-5 73 Citations |
| 1 | Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease. (Cohen RT, Madadi A, Blinder MA, DeBaun MR, Strunk RC, Field JJ) Am J Hematol 2011 Sep;86(9):756-61 53 Citations |
| 2 | Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease. (Hillery CA, Kerstein PC, Vilceanu D, Barabas ME, Retherford D, Brandow AM, Wandersee NJ, Stucky CL) Blood 2011 Sep 22;118(12):3376-83 122 Citations |
| 2 | Methaemalbumin formation in sickle cell disease: effect on oxidative protein modification and HO-1 induction. (Hanson MS, Piknova B, Keszler A, Diers AR, Wang X, Gladwin MT, Hillery CA, Hogg N) Br J Haematol 2011 Aug;154(4):502-11 20 Citations |
| 1 | Outpatient follow-up and rehospitalizations for sickle cell disease patients. (Leschke J, Panepinto JA, Nimmer M, Hoffmann RG, Yan K, Brousseau DC) Pediatr Blood Cancer 2012 Mar;58(3):406-9 45 Citations |
| 1 | Targeting iNKT cells for the treatment of sickle cell disease. (Field JJ, Nathan DG, Linden J) Clin Immunol 2011 Aug;140(2):177-83 39 Citations |
| 2 | The impact of a multidisciplinary pain management model on sickle cell disease pain hospitalizations. (Brandow AM, Weisman SJ, Panepinto JA) Pediatr Blood Cancer 2011 May;56(5):789-93 27 Citations |
| 1 | Delayed hemolytic transfusion reaction in children with sickle cell disease. (de Montalembert M, Dumont MD, Heilbronner C, Brousse V, Charrara O, Pellegrino B, Piguet C, Soussan V, Noizat-Pirenne F) Haematologica 2011 Jun;96(6):801-7 81 Citations |
| 1 | Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. (Ruggeri A, Eapen M, Scaravadou A, Cairo MS, Bhatia M, Kurtzberg J, Wingard JR, Fasth A, Lo Nigro L, Ayas M, Purtill D, Boudjedir K, Chaves W, Walters MC, Wagner J, Gluckman E, Rocha V, Eurocord Registry, Center for International Blood and Marrow Transplant Research, New York Blood Center) Biol Blood Marrow Transplant 2011 Sep;17(9):1375-82 174 Citations |
| 1 | Death due to asthma in two adolescents with sickle cell disease. (Field JJ, Horst J, Strunk RC, White FV, DeBaun MR) Pediatr Blood Cancer 2011 Mar;56(3):454-7 13 Citations |
| 1 | Hydroxyurea use in sickle cell disease: the battle with low prescription rates, poor patient compliance and fears of toxicities. (Brandow AM, Panepinto JA) Expert Rev Hematol 2010 Jun;3(3):255-60 88 Citations |
| 1 | P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. (Polanowska-Grabowska R, Wallace K, Field JJ, Chen L, Marshall MA, Figler R, Gear AR, Linden J) Arterioscler Thromb Vasc Biol 2010 Dec;30(12):2392-9 147 Citations |
| 1 | Humoral rejection after pediatric heart transplantation: a case report. (Stendahl G, Berger S, Ellis T, Gandy K, Mitchell M, Tweddell J, Zangwill S) Prog Transplant 2010 Sep;20(3):288-91 14 Citations |
| 1 | Airway hyperresponsiveness in children with sickle cell anemia. (Field JJ, Stocks J, Kirkham FJ, Rosen CL, Dietzen DJ, Semon T, Kirkby J, Bates P, Seicean S, DeBaun MR, Redline S, Strunk RC) Chest 2011 Mar;139(3):563-568 81 Citations |
| 1 | Hydroxyurea in children with sickle cell disease: practice patterns and barriers to utilization. (Brandow AM, Jirovec DL, Panepinto JA) Am J Hematol 2010 Aug;85(8):611-3 79 Citations |
| 1 | Smoking is associated with an increased risk of acute chest syndrome and pain among adults with sickle cell disease. (Cohen RT, DeBaun MR, Blinder MA, Strunk RC, Field JJ) Blood 2010 May 06;115(18):3852-4 32 Citations |
| 1 | A comparison of analgesic management for emergency department patients with sickle cell disease and renal colic. (Lazio MP, Costello HH, Courtney DM, Martinovich Z, Myers R, Zosel A, Tanabe P) Clin J Pain 2010;26(3):199-205 |
| 1 | Asthma and sickle cell disease: two distinct diseases or part of the same process? (Field JJ, DeBaun MR) Hematology Am Soc Hematol Educ Program 2009:45-53 57 Citations |
| 1 | Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. (Walters MC, Hardy K, Edwards S, Adamkiewicz T, Barkovich J, Bernaudin F, Buchanan GR, Bunin N, Dickerhoff R, Giller R, Haut PR, Horan J, Hsu LL, Kamani N, Levine JE, Margolis D, Ohene-Frempong K, Patience M, Redding-Lallinger R, Roberts IA, Rogers ZR, Sanders JE, Scott JP, Sullivan KM, Multicenter Study of Bone Marrow Transplantation for Sickle Cell Disease) Biol Blood Marrow Transplant 2010 Feb;16(2):263-72 164 Citations |
| 1 | Pulmonary thrombi are not detected by 3D magnetic resonance angiography in adults with sickle cell anemia and an elevated triscuspid regurgitant jet velocity. (Field JJ, Madadi AR, Siegel MJ, Narra V) Am J Hematol 2009 Oct;84(10):686-8 4 Citations |
| 1 | Vaso-occlusive painful events in sickle cell disease: impact on child well-being. (Brandow AM, Brousseau DC, Pajewski NM, Panepinto JA) Pediatr Blood Cancer 2010 Jan;54(1):92-7 82 Citations |
| 1 | Hospital admission for acute painful episode following methacholine challenge in an adolescent with sickle cell disease. (Knight-Perry JE, Field JJ, Debaun MR, Stocks J, Kirkby J, Strunk RC) Pediatr Pulmonol 2009 Jul;44(7):728-30 9 Citations |
| 1 | NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-gamma and CXCR3 chemokines. (Wallace KL, Marshall MA, Ramos SI, Lannigan JA, Field JJ, Strieter RM, Linden J) Blood 2009 Jul 16;114(3):667-76 128 Citations |
| 1 | Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate. (Frei-Jones MJ, Field JJ, DeBaun MR) Pediatr Blood Cancer 2009 Sep;53(3):401-5 27 Citations |
| 1 | Dissatisfaction with hospital care for children with sickle cell disease not due only to race and chronic disease. (Brousseau DC, Mukonje T, Brandow AM, Nimmer M, Panepinto JA) Pediatr Blood Cancer 2009 Aug;53(2):174-8 28 Citations |
| 1 | Acute pain in children and adults with sickle cell disease: management in the absence of evidence-based guidelines. (Field JJ, Knight-Perry JE, Debaun MR) Curr Opin Hematol 2009 May;16(3):173-8 38 Citations |
| 1 | Urinary cysteinyl leukotriene E4 significantly increases during pain in children and adults with sickle cell disease. (Field JJ, Strunk RC, Knight-Perry JE, Blinder MA, Townsend RR, DeBaun MR) Am J Hematol 2009 Apr;84(4):231-3 25 Citations |
| 1 | Leukotriene pathway in sickle cell disease: a potential target for directed therapy. (Knight-Perry J, DeBaun MR, Strunk RC, Field JJ) Expert Rev Hematol 2009 Feb;2(1):57-68 18 Citations |
| 1 | Urinary cysteinyl leukotriene E(4) is associated with increased risk for pain and acute chest syndrome in adults with sickle cell disease. (Field JJ, Krings J, White NL, Yan Y, Blinder MA, Strunk RC, Debaun MR) Am J Hematol 2009 Mar;84(3):158-60 20 Citations |
| 1 | Risk factors for hospital readmission within 30 days: a new quality measure for children with sickle cell disease. (Frei-Jones MJ, Field JJ, DeBaun MR) Pediatr Blood Cancer 2009 Apr;52(4):481-5 76 Citations |
| 1 | Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events. (Brandow AM, Brousseau DC, Panepinto JA) Br J Haematol 2009 Mar;144(5):782-8 38 Citations |
| 1 | Growth of lung function in children with sickle cell anemia. (Field JJ, DeBaun MR, Yan Y, Strunk RC) Pediatr Pulmonol 2008 Nov;43(11):1061-1066 30 Citations |
| 1 | Sibling history of asthma is a risk factor for pain in children with sickle cell anemia. (Field JJ, Macklin EA, Yan Y, Strunk RC, DeBaun MR) Am J Hematol 2008 Nov;83(11):855-7 15 Citations |
| 1 | Methacholine challenge in children with sickle cell disease: a case series. (Strunk RC, Brown MS, Boyd JH, Bates P, Field JJ, DeBaun MR) Pediatr Pulmonol 2008 Sep;43(9):924-9 34 Citations |
| 1 | Histopathology of experimentally induced asthma in a murine model of sickle cell disease. (Nandedkar SD, Feroah TR, Hutchins W, Weihrauch D, Konduri KS, Wang J, Strunk RC, DeBaun MR, Hillery CA, Pritchard KA) Blood 2008 Sep 15;112(6):2529-38 47 Citations |
| 1 | Parental perception of quality of hospital care for children with sickle cell disease. (Kam J, Panepinto JA, Brandow AM, Brousseau DC) WMJ 2008 May;107(3):131-5 4 Citations |
| 1 | Elevated urinary leukotriene E4 levels are associated with hospitalization for pain in children with sickle cell disease. (Jennings JE, Ramkumar T, Mao J, Boyd J, Castro M, Field JJ, Strunk RC, DeBaun MR) Am J Hematol 2008 Aug;83(8):640-3 39 Citations |
| 1 | Enuresis is a common and persistent problem among children and young adults with sickle cell anemia. (Field JJ, Austin PF, An P, Yan Y, DeBaun MR) Urology 2008 Jul;72(1):81-4 25 Citations |
| 1 | Longitudinal analysis of pulmonary function in adults with sickle cell disease. (Field JJ, Glassberg J, Gilmore A, Howard J, Patankar S, Yan Y, Davies SC, Debaun MR, Strunk RC) Am J Hematol 2008 Jul;83(7):574-6 32 Citations |
| 1 | Limitations of clinical trials in sickle cell disease: a case study of the Multi-center Study of Hydroxyurea (MSH) trial and the Stroke Prevention (STOP) trial. (Debaun MR, Field JJ) Hematology Am Soc Hematol Educ Program 2007:482-8 17 Citations |
| 1 | The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis. (Brousseau DC, McCarver DG, Drendel AL, Divakaran K, Panepinto JA) J Pediatr 2007 Jun;150(6):623-6 54 Citations |
| 1 | Laparoscopic versus open abdominal surgery in children with sickle cell disease is associated with a shorter hospital stay. (Goers T, Panepinto J, Debaun M, Blinder M, Foglia R, Oldham KT, Field JJ) Pediatr Blood Cancer 2008 Mar;50(3):603-6 32 Citations |
| 1 | Matched-related donor transplantation for sickle cell disease: report from the Center for International Blood and Transplant Research. (Panepinto JA, Walters MC, Carreras J, Marsh J, Bredeson CN, Gale RP, Hale GA, Horan J, Hows JM, Klein JP, Pasquini R, Roberts I, Sullivan K, Eapen M, Ferster A, Non-Malignant Marrow Disorders Working Committee, Center for International Blood and Marrow Transplant Research) Br J Haematol 2007 Jun;137(5):479-85 153 Citations |
| 1 | Emergency department management of acute pain episodes in sickle cell disease. (Tanabe P, Myers R, Zosel A, Brice J, Ansari AH, Evans J, Martinovich Z, Todd KH, Paice JA) Acad Emerg Med 2007 May;14(5):419-25 102 Citations |
| 1 | Effect of myeloablative bone marrow transplantation on growth in children with sickle cell anaemia: results of the multicenter study of haematopoietic cell transplantation for sickle cell anaemia. (Eggleston B, Patience M, Edwards S, Adamkiewicz T, Buchanan GR, Davies SC, Dickerhoff R, Donfield S, Feig SA, Giller RH, Haight A, Horan J, Hsu LL, Kamani N, Lane P, Levine JE, Margolis D, Moore TB, Ohene-Frempong K, Redding-Lallinger R, Roberts IA, Rogers ZR, Sanders JE, Scott JP, Sleight B, Thompson AA, Sullivan KM, Walters MC, Multicenter Study of HCT for SCA) Br J Haematol 2007 Feb;136(4):673-6 45 Citations |
| 1 | The effect of acute pain crisis on exhaled nitric oxide levels in children with sickle cell disease. (Pawar SS, Panepinto JA, Brousseau DC) Pediatr Blood Cancer 2008 Jan;50(1):111-3 4 Citations |
| 1 | Perioperative management of sickle cell disease children undergoing adenotonsillectomy. (Duke RL, Scott JP, Panepinto JA, Flanary VA) Otolaryngol Head Neck Surg 2006 Mar;134(3):370-3 22 Citations |
| 1 | Erythrocyte adhesion is modified by alterations in cellular tonicity and volume. (Wandersee NJ, Punzalan RC, Rettig MP, Kennedy MD, Pajewski NM, Sabina RL, Paul Scott J, Low PS, Hillery CA) Br J Haematol 2005 Nov;131(3):366-77 24 Citations |
| 1 | Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates. (Hematti P, Tuchman S, Larochelle A, Metzger ME, Donahue RE, Tisdale JF) Stem Cells 2004;22(6):1062-9 18 Citations |
| 1 | Patient-controlled analgesia for sickle cell pain crisis in a pediatric emergency department. (Melzer-Lange MD, Walsh-Kelly CM, Lea G, Hillery CA, Scott JP) Pediatr Emerg Care 2004 Jan;20(1):2-4 46 Citations |
| 1 | Hypoxia-induced acute lung injury in murine models of sickle cell disease. (Pritchard KA Jr, Ou J, Ou Z, Shi Y, Franciosi JP, Signorino P, Kaul S, Ackland-Berglund C, Witte K, Holzhauer S, Mohandas N, Guice KS, Oldham KT, Hillery CA) Am J Physiol Lung Cell Mol Physiol 2004 Apr;286(4):L705-14 69 Citations |
| 1 | Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. (Talano JA, Hillery CA, Gottschall JL, Baylerian DM, Scott JP) Pediatrics 2003 Jun;111(6 Pt 1):e661-5 163 Citations |
| 1 | L-4F, an apolipoprotein A-1 mimetic, dramatically improves vasodilation in hypercholesterolemia and sickle cell disease. (Ou J, Ou Z, Jones DW, Holzhauer S, Hatoum OA, Ackerman AW, Weihrauch DW, Gutterman DD, Guice K, Oldham KT, Hillery CA, Pritchard KA Jr) Circulation 2003 May 13;107(18):2337-41 140 Citations |
| 1 | Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. (Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, Gladwin MT) Nat Med 2002 Dec;8(12):1383-9 1088 Citations |
| 1 | CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. (Febbraio M, Hajjar DP, Silverstein RL) J Clin Invest 2001 Sep;108(6):785-91 1008 Citations |
| 1 | Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. (Walters MC, Storb R, Patience M, Leisenring W, Taylor T, Sanders JE, Buchanan GE, Rogers ZR, Dinndorf P, Davies SC, Roberts IA, Dickerhoff R, Yeager AM, Hsu L, Kurtzberg J, Ohene-Frempong K, Bunin N, Bernaudin F, Wong WY, Scott JP, Margolis D, Vichinsky E, Wall DA, Wayne AS, Pegelow C, Redding-Lallinger R, Wiley J, Klemperer M, Mentzer WC, Smith FO, Sullivan KM) Blood 2000 Mar 15;95(6):1918-24 347 Citations |
| 1 | Breast cancer in Poland syndrome. (Havlik RJ, Sian KU, Wagner JD, Binford R, Broadie TA) Plast Reconstr Surg 1999 Jul;104(1):180-2 29 Citations |
| 1 | Low-density lipoprotein susceptibility to oxidation and cytotoxicity to endothelium in sickle cell anemia. (Belcher JD, Marker PH, Geiger P, Girotti AW, Steinberg MH, Hebbel RP, Vercellotti GM) J Lab Clin Med 1999 Jun;133(6):605-12 36 Citations |
| 1 | Prevalence of microalbuminuria in children with sickle cell disease. (Dharnidharka VR, Dabbagh S, Atiyeh B, Simpson P, Sarnaik S) Pediatr Nephrol 1998 Aug;12(6):475-8 73 Citations |
| 1 | Diagnostic value of anemia, red blood cell morphology, and reticulocyte count for sickle cell disease. (Losek JD, Hellmich TR, Hoffman GM) Ann Emerg Med 1992 Aug;21(8):915-8 9 Citations |
